blank Quick help
blank Maintenance news
blank News flashes
blank Related links

Extract from the Register of European Patents

EP About this file: EP0828480

EP0828480 - NOVEL PHARMACEUTICAL PELLET FORMULATION [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  13.06.2008
Database last updated on 05.04.2025
Most recent event   Tooltip13.06.2008Revocation of patentpublished on 16.07.2008  [2008/29]
Applicant(s)For all designated states
Mepha AG
Dornacherstrasse 114
CH-4147 Aesch / CH
[1998/12]
Inventor(s)01 / SCHEIWE, Max, Werner
Adolf Strübe-Str. 16
D-79689 Maulburg / DE
02 / VILLIGER, Thomas
Schlossbergstrasse 3
CH-4132 Muttenz / CH
[1998/34]
Representative(s)Braun, André jr.
Braunpat Braun Eder AG
Reussstrasse 22
Postfach
4015 Basel / CH
[N/P]
Application number, filing date96914833.724.05.1996
[1998/12]
WO1996CH00203
Priority number, dateCH1995000154224.05.1995         Original published format: CH 154295
[1998/12]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9637195
Date:28.11.1996
Language:DE
[1996/52]
Type: A1 Application with search report 
No.:EP0828480
Date:18.03.1998
Language:DE
The application published by WIPO in one of the EPO official languages on 28.11.1996 takes the place of the publication of the European patent application.
[1998/12]
Type: B1 Patent specification 
No.:EP0828480
Date:29.08.2001
Language:DE
[2001/35]
Search report(s)International search report - published on:EP28.11.1996
ClassificationIPC:A61K9/16, A61K9/50
[1998/12]
CPC:
A61K9/5078 (EP,US); A61P1/04 (EP); A61K9/501 (EP,US)
Designated contracting statesAT,   DE,   DK,   ES,   FI,   FR,   GB,   LU,   NL,   PT,   SE [1998/12]
Extension statesLV29.12.1997
SI29.12.1997
TitleGerman:NEUE PHARMAZEUTISCHE PELLETFORMULIERUNG[1998/12]
English:NOVEL PHARMACEUTICAL PELLET FORMULATION[1998/12]
French:NOUVELLE FORMULATION PHARMACEUTIQUE DE PELLETS[1998/12]
Entry into regional phase29.12.1997National basic fee paid 
29.12.1997Designation fee(s) paid 
29.12.1997Examination fee paid 
Examination procedure17.12.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.11.1997Amendment by applicant (claims and/or description)
29.12.1997Examination requested  [1998/12]
27.07.1999Despatch of a communication from the examining division (Time limit: M04)
18.11.1999Reply to a communication from the examining division
08.05.2000Despatch of a communication from the examining division (Time limit: M02)
17.06.2000Reply to a communication from the examining division
24.10.2000Despatch of communication of intention to grant (Approval: Yes)
14.12.2000Communication of intention to grant the patent
26.03.2001Fee for grant paid
26.03.2001Fee for publishing/printing paid
Opposition(s)Opponent(s)01  23.05.2002  06.06.2002  ADMISSIBLE
AstraZeneca AB
c/o Global Intellectual Property, Patents
151 85 Södertälje / SE
 [2002/30]
03.07.2002Invitation to proprietor to file observations on the notice of opposition
01.11.2002Reply of patent proprietor to notice(s) of opposition
22.07.2004Date of oral proceedings
27.08.2004Despatch of interlocutory decision in opposition
27.08.2004Despatch of minutes of oral proceedings
19.02.2008Legal effect of revocation of patent [2008/29]
19.02.2008Despatch of communication that the patent will be revoked
Appeal following opposition25.10.2004Appeal received No.  T1265/04
23.12.2004Statement of grounds filed
19.02.2008Result of appeal procedure: revocation of the patent
19.02.2008Date of oral proceedings
Fees paidRenewal fee
02.06.1998Renewal fee patent year 03
31.05.1999Renewal fee patent year 04
31.05.2000Renewal fee patent year 05
31.05.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFI29.08.2001
FR29.08.2001
GB29.08.2001
NL29.08.2001
DK29.11.2001
SE29.11.2001
ES28.02.2002
AT24.05.2002
LU24.05.2002
[2006/14]
Cited inInternational search[X]EP0526862  (VECTORPHARMA INT [IT]) [X] 1-13* column W *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.